Last reviewed · How we verify

NCT05231499

Immunity and Nasal Fungal Colonization

Completed Last updated 9 February 2022
What this trial tests

trial testing nasal irrigation in Colonization, Asymptomatic in 58 participants. Completed in 27 July 2020.

Timeline
20 August 2018
Primary endpoint
20 July 2020
27 July 2020

Quick facts

Lead sponsorTaichung Veterans General Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment58
Start date20 August 2018
Primary completion20 July 2020
Estimated completion27 July 2020
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Taichung Veterans General Hospital

Who can join

Eligibility, any sex, with Colonization, Asymptomatic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Fungal colonization causes opportunistic infection that may manifest when the host's immune status deteriorates. The purpose of this study was to determine the prevalence of fungal colonization in immunocompromised subjects compared to healthy controls.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of nasal irrigation

Trials testing the same drug.

Other recruiting trials for Colonization, Asymptomatic

Currently open trials in the same condition.

Other Taichung Veterans General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05231499.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing